Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
-174K
-
Total reported value, excl. options
-
$7.66B
-
Value change
-
+$6.26M
-
Put/Call ratio
-
0.79
-
Number of buys
-
135
-
Number of sells
-
-124
-
Price
-
$74.16
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2018
332 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2018.
DEXCOM INC - Common Stock (DXCM) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 392M outstanding shares and own 26.39% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.93M shares), FMR LLC (7.34M shares), VANGUARD GROUP INC (7.15M shares), JANUS HENDERSON GROUP PLC (6.92M shares), WELLINGTON MANAGEMENT GROUP LLP (6.51M shares), BAILLIE GIFFORD & CO (5.42M shares), Capital World Investors (5.26M shares), MORGAN STANLEY (4.32M shares), BlackRock Inc. (3.89M shares), and BROWN ADVISORY INC (3.59M shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.